HK1258851A1 - 四氫萘雌激素受體調節劑及其用途 - Google Patents
四氫萘雌激素受體調節劑及其用途Info
- Publication number
- HK1258851A1 HK1258851A1 HK19101321.7A HK19101321A HK1258851A1 HK 1258851 A1 HK1258851 A1 HK 1258851A1 HK 19101321 A HK19101321 A HK 19101321A HK 1258851 A1 HK1258851 A1 HK 1258851A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- tetrahydronaphthalene
- estrogen receptor
- receptor modulators
- modulators
- estrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562252707P | 2015-11-09 | 2015-11-09 | |
PCT/EP2016/076904 WO2017080966A1 (en) | 2015-11-09 | 2016-11-08 | Tetrahydronaphthalene estrogen receptor modulators and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1258851A1 true HK1258851A1 (zh) | 2019-11-22 |
Family
ID=57241106
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK19101321.7A HK1258851A1 (zh) | 2015-11-09 | 2019-01-25 | 四氫萘雌激素受體調節劑及其用途 |
Country Status (6)
Country | Link |
---|---|
US (1) | US10399939B2 (zh) |
EP (1) | EP3374356A1 (zh) |
JP (1) | JP6920295B2 (zh) |
CN (1) | CN108349952A (zh) |
HK (1) | HK1258851A1 (zh) |
WO (1) | WO2017080966A1 (zh) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017100715A1 (en) | 2015-12-09 | 2017-06-15 | The Board Of Trustees Of The University Of Illinois | Benzothiophene-based selective estrogen receptor downregulator compounds |
US10125135B2 (en) | 2016-04-20 | 2018-11-13 | Astrazeneca Ab | Chemical compounds |
WO2018019793A1 (en) | 2016-07-25 | 2018-02-01 | Astrazeneca Ab | N-(2-(4-((1r,3r)-3-methyl-2,3,4,9-tetrahydro-1h-pyrido[3,4-b]indol-1-yl)phenoxy)ethyl)propan-1-amine derivatives and related compounds as selective down-regulators of the estrogen receptor for treating cancer |
US10131663B2 (en) | 2016-10-24 | 2018-11-20 | Astrazeneca Ab | Chemical compounds |
NZ754865A (en) | 2017-01-06 | 2023-07-28 | G1 Therapeutics Inc | Combination therapy for the treatment of cancer |
DK3494116T3 (da) | 2017-01-30 | 2020-01-27 | Astrazeneca | Østrogenreceptormodulatorer |
BR112020014746A2 (pt) * | 2018-01-22 | 2020-12-08 | Radius Pharmaceuticals, Inc. | Compostos moduladores de receptor de estrogênio |
WO2020037203A2 (en) | 2018-08-17 | 2020-02-20 | Genentech, Inc. | Diagnostic and therapeutic methods for the treatment of breast cancer |
CN117924262A (zh) * | 2022-10-14 | 2024-04-26 | 中国科学院上海药物研究所 | 二氢苯并噻喃类衍生物及其制备方法和用途 |
KR20240078553A (ko) * | 2022-11-25 | 2024-06-04 | 재단법인 대구경북첨단의료산업진흥재단 | 선택적 에스트로겐 수용체 조절제로서의 신규 화합물 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5552412A (en) * | 1995-01-09 | 1996-09-03 | Pfizer Inc | 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis |
CZ2007373A3 (cs) * | 2007-05-29 | 2008-12-10 | Zentiva, A. S | Zpusob prípravy lasofoxifenu |
CA2819299A1 (en) * | 2010-12-24 | 2012-06-28 | Merck Sharp & Dohme B.V. | N-substituted azetidine derivatives |
JP6807841B2 (ja) * | 2014-12-18 | 2021-01-06 | エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト | エストロゲン受容体モジュレーター及びその使用 |
-
2016
- 2016-11-08 US US15/345,958 patent/US10399939B2/en active Active
- 2016-11-08 EP EP16791412.6A patent/EP3374356A1/en not_active Withdrawn
- 2016-11-08 JP JP2018523503A patent/JP6920295B2/ja active Active
- 2016-11-08 WO PCT/EP2016/076904 patent/WO2017080966A1/en active Application Filing
- 2016-11-08 CN CN201680064913.7A patent/CN108349952A/zh active Pending
-
2019
- 2019-01-25 HK HK19101321.7A patent/HK1258851A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CN108349952A (zh) | 2018-07-31 |
JP2018536658A (ja) | 2018-12-13 |
WO2017080966A1 (en) | 2017-05-18 |
EP3374356A1 (en) | 2018-09-19 |
JP6920295B2 (ja) | 2021-08-18 |
US20170129855A1 (en) | 2017-05-11 |
US10399939B2 (en) | 2019-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1247199A1 (zh) | 雌激素受體調節劑及其用途 | |
IL285318A (en) | Estrogen receptor modulators | |
IL284424B (en) | History of tetrahydronaphthalene and tetrahydroisoquinoline as estrogen receptor antagonists | |
IL281240A (en) | Androgen receptor modulator and uses | |
HK1258851A1 (zh) | 四氫萘雌激素受體調節劑及其用途 | |
HK1248683A1 (zh) | 雜環雌激素受體調節劑及其用途 | |
ZA201807731B (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
HK1214532A1 (zh) | 雌激素受體調節劑及其用途 | |
IL264514B (en) | Spiro-lactam nmda receptor modulators and their uses | |
IL264488A (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
IL286107A (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
EP3490994C0 (en) | SPIRO-LACTAM AND BIS-SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND THEIR USE | |
IL268263A (en) | Estrogen receptor modulators | |
PL3347376T3 (pl) | Nowy receptor IGFR-podobny i jego zastosowania | |
EP3224230A4 (en) | Estrogen receptor modulators |